Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MDUFMA 101: Pay User Fees First, Recoup Overpayments Later, FDA Counsels

This article was originally published in The Gray Sheet

Executive Summary

Manufacturers that have yet to qualify as a "small business" under MDUFMA should pay the full premarket submission user fee amount until FDA grants small company status, the agency is advising

You may also be interested in...



FDA Guidances Outline User Fee Collection Policy, Small Business Criteria

Modular premarket applications will be exempt from device user fees if FDA received the initial module of the PMA prior to Oct. 1, 2002

User Fee Submission Process To Be Explained In Upcoming FR Notice

FDA will likely publish a Federal Register notice after the Nov. 5 elections detailing the steps companies must take to submit device user fees, the agency says

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018201

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel